pubmed.ncbi.nlm.nih.gov

Phenylbutyrate-induced apoptosis is associated with inactivation of NF-kappaB IN HT-29 colon cancer cells - PubMed

Phenylbutyrate-induced apoptosis is associated with inactivation of NF-kappaB IN HT-29 colon cancer cells

Rena Feinman et al. Cancer Chemother Pharmacol. 2002 Jan.

Abstract

Purpose: Cytotoxic chemotherapy has been used to treat patients with metastatic colorectal cancer with limited success. Therefore novel chemotherapeutic approaches are needed. Based on encouraging preclinical data, there has been an interest in developing derivatives of butyrate as clinically applicable agents. The purpose of this study was to investigate the effects of phenylbutyrate (PB), a butyrate analogue, on the cell growth and apoptosis in a colon cancer cell model.

Methods: Growth curves, flow cytometric studies, Western blotting, DNA binding assays and transient transfection experiments were performed in vitro using the colon cancer cell line HT-29 after exposure to PB.

Results: Exposure of HT-29 colon cancer cells to PB resulted in growth inhibition and induction of apoptosis as measured by annexin V staining. This increase in apoptosis was associated with a decrease in mitochondrial membrane potential, an increase in caspase-3 activity and a decrease in intact PARP protein levels. Since NF-kappaB plays a pivotal role in the regulation of apoptosis, we explored the effects of PB on the DNA binding and transcriptional activity of this transcription factor. After PB treatment, NF-kappaB-DNA binding was markedly decreased and specifically, this decreased DNA binding was observed in the p50:p65 heterodimer. The decreased NF-kappaB DNA binding was observed as early as 3 h after PB treatment, while no apparent changes in annexin V binding were detected until 12 h after PB treatment. Untreated HT-29 cells transfected with a kappaB-luciferase reporter plasmid demonstrated significant constitutive activity of the kappaB binding site, which was markedly decreased after treating the cells with PB.

Conclusion: These results suggest that PB-induced apoptosis may be partly regulated through the inactivation of NF-kappaB. PB, an oral butyrate analogue, may have therapeutic potential in colon cancer.

PubMed Disclaimer

Cited by

Clinical and experimental applications of sodium phenylbutyrate.
Iannitti T, Palmieri B. Iannitti T, et al. Drugs R D. 2011 Sep 1;11(3):227-49. doi: 10.2165/11591280-000000000-00000. Drugs R D. 2011. PMID: 21902286 Free PMC article. Review.
Chemical chaperone, TUDCA unlike PBA, mitigates protein aggregation efficiently and resists ER and non-ER stress induced HepG2 cell death.
Uppala JK, Gani AR, Ramaiah KVA. Uppala JK, et al. Sci Rep. 2017 Jun 19;7(1):3831. doi: 10.1038/s41598-017-03940-1. Sci Rep. 2017. PMID: 28630443 Free PMC article.
Aberrant levels of histone H3 acetylation induce spermatid anomaly in mouse testis.
Dai L, Endo D, Akiyama N, Yamamoto-Fukuda T, Koji T. Dai L, et al. Histochem Cell Biol. 2015 Feb;143(2):209-24. doi: 10.1007/s00418-014-1283-1. Epub 2014 Oct 19. Histochem Cell Biol. 2015. PMID: 25326673
Inhibition of IkappaB kinase by a new class of retinoid-related anticancer agents that induce apoptosis.
Bayon Y, Ortiz MA, Lopez-Hernandez FJ, Gao F, Karin M, Pfahl M, Piedrafita FJ. Bayon Y, et al. Mol Cell Biol. 2003 Feb;23(3):1061-74. doi: 10.1128/MCB.23.3.1061-1074.2003. Mol Cell Biol. 2003. PMID: 12529410 Free PMC article.
Complementary effects of HDAC inhibitor 4-PB on gap junction communication and cellular export mechanisms support restoration of chemosensitivity of PDAC cells.
Ammerpohl O, Trauzold A, Schniewind B, Griep U, Pilarsky C, Grutzmann R, Saeger HD, Janssen O, Sipos B, Kloppel G, Kalthoff H. Ammerpohl O, et al. Br J Cancer. 2007 Jan 15;96(1):73-81. doi: 10.1038/sj.bjc.6603511. Epub 2006 Dec 12. Br J Cancer. 2007. PMID: 17164759 Free PMC article.

Phenylbutyrate-induced apoptosis is associated with inactivation of NF-kappaB IN HT-29 colon cancer cells - PubMed